A groundbreaking clinical trial is exploring whether bilateral cochlear implants, two implants instead of one, can transform the lives of profoundly deaf adults in ways that single implants cannot. The LUCIA trial, led by the University of Cambridge and supported by researchers at the University of Birmingham, will recruit over 250 adults across 14 NHS hospitals to compare the benefits of unilateral (one implant) versus bilateral (two implants) cochlear implants.

How Do Cochlear Implants Work Differently Than Hearing Aids?

Unlike hearing aids, which amplify sound and work best for mild to moderate hearing loss, cochlear implants bypass damaged parts of the inner ear and stimulate the hearing nerve directly. This fundamental difference makes them suitable for people with profound hearing loss who cannot benefit from traditional amplification. Each year, more than 1,000 adults in the UK receive cochlear implants to restore hearing, yet current NHS guidance typically supports implantation in one ear only, despite growing evidence that two implants offer substantial additional benefits.

What Makes Bilateral Implants Different From Single Implants?

The research team points to compelling evidence from children who receive bilateral implants. According to experts, bilateral implants provide three-dimensional hearing, enabling recipients to hear more naturally than with a single implant, with improved access to sound and better engagement with society. Adults who have become deaf later in life are now asking for the same hearing opportunities that children routinely receive.

"Children routinely receive bilateral cochlear implants. These can provide 3-dimensional hearing, enabling them to hear more naturally than unilateral, with improved access to sound and better engagement with society. Adults tell us, and I agree, that they should be given the same hearing opportunities as children," stated Professor Debi Vickers, co-lead and speech and hearing scientist at the University of Cambridge.

Professor Debi Vickers, Co-lead and Speech and Hearing Scientist at the University of Cambridge

The potential benefits extend beyond hearing alone. Researchers expect bilateral implants to result in reduced social isolation, enriched communication, improved mental health, and better overall quality of life for adults who have experienced profound hearing loss.

What Will the LUCIA Trial Actually Measure?

The trial, funded by the National Institute for Health and Care Research (NIHR), will monitor participants for 12 months after surgery to assess multiple outcomes. The study will evaluate not only hearing improvements but also the economic benefits and cost of bilateral implants for the NHS, potentially making the case for broader access to this intervention.

The University of Birmingham is leading a critical component of the research: the qualitative work package. This includes in-depth interviews with participants to understand their lived experiences of the intervention, as well as a process evaluation exploring how bilateral cochlear implant services are implemented across different NHS cochlear implant centers.

How Is This Research Designed to Capture Real-World Impact?

• Collaborative Interviews: The qualitative study brings together researchers and cochlear implant users as co-investigators to conduct interviews shaped by lived experience, allowing different topics, priorities, and insights to emerge that might not arise in traditional researcher-led interviews.
• Comprehensive Outcome Measures: The trial will assess listening ability, communication effectiveness, wellbeing, and quality of life in relation to bilateral implants, providing depth and context beyond standard hearing tests.
• Economic Evaluation: Researchers will analyze the cost-effectiveness of bilateral implants for the NHS, potentially influencing future funding decisions and access to this technology for deaf adults.

"The qualitative study within LUCIA is designed to bring lived experience into the heart of the trial, and I am delighted to be working in partnership with cochlear implant users to co-deliver the interviews. This is genuinely collaborative research," explained Dr. Sarah Hughes, Research Fellow and study co-investigator at the University of Birmingham.

Dr. Sarah Hughes, Research Fellow at the University of Birmingham

The trial is expected to begin recruiting patients in autumn 2026. This research addresses a significant gap in current NHS practice, where bilateral implants are standard for children but rarely offered to adults, despite evidence suggesting they could provide comparable benefits. By rigorously evaluating both the clinical and economic outcomes, the LUCIA trial could reshape how hearing restoration is approached for profoundly deaf adults in the UK and potentially influence practice internationally.